Automated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage kidney disease. The results found that they were safe and able to offer ...

Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 J.P. Morgan Healthcare Conference. “These are growth-drivers ...

The CONTOUR Link wirelessly transmits blood glucose test results to compatible Medtronic insulin pumps and continuous glucose monitoring systems making insulin dosing easier than ever.

Medicare Part B will cover insulin pumps and insulin if a person meets the necessary criteria. Part D will cover prescription insulin and related medical supplies for diabetes. Under Medicare Part ...

Some monitors also may be combined with an insulin pump. Other CGM devices include user-friendly, cloud-based reporting software. When blood glucose information is received by a smart device, it is ...

aNorwich Clinical Trials Unit, University of East Anglia, Norwich, UK ...

Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). Insulin dosing is a multistep process that often requires careful ...

Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older persons with type 1 diabetes when compared to sensor-augmented pump ...